IPSC
Companies
NASDAQ
Century Therapeutics Inc.
Health Care
$0.59
-$0.43 (-42.62%)
Price Chart
Overview
About IPSC
Century Therapeutics, Inc. specializes in adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies as well as provides testing and research services.
Market Cap
$244.5M
Volume
337.7K
Avg. Volume
405.5K
P/E Ratio
-0.4148148
Dividend Yield
0.00%
Employees
133.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.83
Moderate Correlation
Volatility
High (0.79)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, IPSC shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$244.5M
Volume337.7K
P/E Ratio-0.41
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 9, 2024Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025